NSE filing, NSE: LORDSCHLO. Summary written from the filing by ALFA Finder's alert engine.
Lords Chloro Alkali Ltd: key numbers
- Share price
- ₹133.18
- Market cap
- ₹381.6 Cr
- Revenue (annual)
- ₹390.1 Cr
- Net profit (annual)
- ₹28.49 Cr
- P/E (TTM)
- 11.6×Sector 34.1×
- Promoter holding
- 74.97%+0.00% QoQ
- FII holding
- 0.07%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Lords Chloro Alkali Ltd
All →Lords Chloro Alkali Board Meeting Date
Lords Chloro Alkali has scheduled its Board Meeting for 3 November 2026 to consider Q2 and H1 2026-27 un-audited results. The trading window remains closed from 1 October 2026.
Lords Chloro Alkali Other Announcement
Lords Chloro Alkali Ltd has submitted its quarterly shareholding pattern report. This disclosure details the equity distribution between promoter and public shareholders for the period ending September 2026.
Lords Chloro Alkali Annual General Meeting
Lords Chloro Alkali held its 47th AGM on September 11, 2026. Resolutions on financials, director appointments, borrowing limits, and an ESOP scheme were considered.
Lords Chloro Alkali Production Started
Lords Chloro Alkali Ltd has commissioned a 14.5 MW (AC) captive solar power plant with BESS in Rajasthan. The project increases the company's renewable energy capacity.
- solar power plant capacity
- 14.5 MW
Lords Chloro Alkali Annual Report
Lords Chloro Alkali Limited has submitted its Annual Report for the financial year 2025-26, fulfilling SEBI listing requirements.
Lords Chloro Alkali Annual General Meeting
Lords Chloro Alkali Limited has issued the notice for its 47th Annual General Meeting to be held on September 11, 2026. The filing includes details on book closure and e-voting.
Other employee stock options announcements
All →Aye Finance Employee Stock Options
Aye Finance's employee welfare trust transferred 89,501 equity shares to grantees on exercising ESOP options. The share capital remains unchanged, so no new issuance occurs.
Aarti Pharmalabs Employee Stock Options
Aarti Pharmalabs granted 850 stock options to employees under its PSOP 2023 at Rs.5 exercise price. This is an employee incentive grant, not a capital raise.
OnEMI Technology Solutions Employee Stock Options
OnEMI Technology allotted 69,000 equity shares on exercise of employee stock options under the Kissht ESOP 2022 plan. The shares rank pari passu with existing equity.
Bliss GVS Pharma Employee Stock Options
Bliss GVS Pharma seeks shareholder approval via postal ballot for new employee stock option plans 2026. Up to 26,50,000 options are proposed; voting closes November 27, 2026.
Bandhan Bank Employee Stock Options
Bandhan Bank's board granted 32,98,871 stock options under ESOP Series 1 (Tranche 9) at Rs 151.91 per option. The options vest over four years, with each option convertible into one equity share.
Maxvolt Energy Industries Employee Stock Options
Maxvolt Energy granted 5,01,726 ESOPs to six employees under its MEIL ESOP 2025 scheme at exercise prices of ₹30 and ₹45. Options vest over four years, with exercise windows following vesting.
- Execution
- Vesting over 4 years from grant (25% at 2nd, 25% at 3rd, 50% at 4th anniversary); exercise over 3 years from each vesting date